James Tananbaum Net Worth & Insider Trades

James Tananbaum - Director, Kinnate Biopharma Inc

As of June 15, 2022

What is James Tananbaum's Net Worth?

The current estimated net worth of Kinnate Biopharma Inc's Director, James Tananbaum, is estimated to be about $213.17M . James Tananbaum owns about 125,000 units of Kinnate Biopharma Inc common stock. In the last 2 years at Kinnate Biopharma Inc, James Tananbaum has sold an estimated value of $0 worth.

What is James Tananbaum's Past Insider Trading?

James Tananbaum's largest purchase order was 1,000,000 units , worth over $20M on December 4, 2020. In total, James Tananbaum has made about 4 transactions over 2 years of their time at Kinnate Biopharma Inc. James Tananbaum usually trades in December, with the busiest year in 2020.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is James Tananbaum's' Mailing Address?

  • Mailing address is 3052 Pacific Avenue San Francisco CA 94115 CA

Kinnate Biopharma Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Nima Farzan 2020 $359,423 - $4,370,048 - $329 $4,945,454
Nima Farzan 2019 - - - - - -
Mark Meltz 2020 $267,173 - $1,268,433 - $392392 $1,676,264
Mark Meltz 2019 - - - - - -
Eric Murphy, Ph.D. 2020 $376,115 - $983,188983,188 - $447 $1,529,002
Eric Murphy, Ph.D. 2019 $336,156 - - - $344 $403,775403,775
Steve Kaldor, Ph.D. 2020 $84,172 84,172 - - - $23,249 $107,421 107,421
Steve Kaldor, Ph.D. 2019 $336,156 $67,275 67,275 - $67,275 67,275 $1,481 1,481 $404,912404,912
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1797768/000114036121015081/nc10022093x1_def14a.htm

What are Kinnate Biopharma Inc's Past Insider Trades?

Kinnate Biopharma Inc's most recent insider trade came on March 15, 2022 by Thomas Richard Williams who bought 40,000 units worth $338.85K . In the last 2 years, insiders at Kinnate Biopharma Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Carl Gordon, Director,  James Tananbaum, Director,  and Thomas Richard Williams, Chief Medical Officer .

Kinnate Biopharma Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1